Login to Your Account

Financings Roundup

Prosensa Leads More Biotechs into IPO Parade

By Marie Powers
Staff Writer

Wednesday, May 29, 2013
The sizzling initial public offering (IPO) market gained two more biopharma contestants with a third moving carefully toward it, as Prosensa Therapeutics BV filed an F-1 registration statement, Evoke Pharma Inc. filed an S-1 and Oculus Innovative Sciences Inc. disclosed that subsidiary Ruthigen Inc. submitted a confidential draft registration statement to the SEC.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription